%0 Journal Article
%A Arévalos, Victor
%A Ortega-Paz, Luis
%A Fernandez-Rodríguez, Diego
%A Alfonso Jiménez-Díaz, Víctor
%A Rius, Jordi Bañeras
%A Campo, Gianluca
%A Rodríguez-Santamarta, Miguel
%A de Prado, Armando Pérez
%A Gómez-Menchero, Antonio
%A Díaz Fernández, José Francisco
%A Scardino, Claudia
%A Gonzalo, Nieves
%A Pernigotti, Alberto
%A Alfonso, Fernando
%A Jesús Amat-Santos, Ignacio
%A Silvestro, Antonio
%A Ielasi, Alfonso
%A María de la Torre, José
%A Bastidas, Gabriela
%A Gómez-Lara, Josep
%A Sabaté, Manel
%A Brugaletta, Salvatore
%A CV COVID-19 Registry Investigators
%T Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
%D 2021
%U http://hdl.handle.net/10668/18274
%X Patients presenting with the coronavirus-2019 disease (COVID-19) may have a high risk of cardiovascular adverse events, including death from cardiovascular causes. The long-term cardiovascular outcomes of these patients are entirely unknown. We aim to perform a registry of patients who have undergone a diagnostic nasopharyngeal swab for SARS-CoV-2 and to determine their long-term cardiovascular outcomes. This is a multicenter, observational, retrospective registry to be conducted at 17 centers in Spain and Italy (ClinicalTrials.gov number: NCT04359927). Consecutive patients older than 18 years, who underwent a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for SARS-CoV2 in the participating institutions, will be included since March 2020, to August 2020. Patients will be classified into two groups, according to the results of the RT-PCR: COVID-19 positive or negative. The primary outcome will be cardiovascular mortality at 1 year. The secondary outcomes will be acute myocardial infarction, stroke, heart failure hospitalization, pulmonary embolism, and serious cardiac arrhythmias, at 1 year. Outcomes will be compared between the two groups. Events will be adjudicated by an independent clinical event committee. The results of this registry will contribute to a better understanding of the long-term cardiovascular implications of the COVID19.
%~